Noveome Biotherapeutics
Pittsburgh
About Noveome Biotherapeutics
Noveome Biotherapeutics is a clinical-stage company focusing on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company's products contain a variety of biologic components at physiological concentrations that work together and synergistically to produce anti-inflammatory, neuroprotective, anti-apoptotic, and vascular integrity preservative properties.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $73.6M
- Funding stage: Late Stage Venture
- Last round: Series E (Aug 2023)
- Website: noveome.com
- Phone: (412)402-9914
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/noveome-biotherapeutics-55045 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.